Alnylam Pharmaceuticals recently released their Q4 financial results, revealing a mixed bag of outcomes. The company’s total TTR net product revenues from ONPATTRO and AMVUTTRA for the full year 2025 are projected to be between $1.2 billion and $1.4 billion. This forecast reflects a significant growth potential, showcasing the company’s confidence in its product portfolio. However, the Q4 results themselves were not as straightforward. While some aspects of their financial performance met expectations, others fell short, creating a complex picture for investors and analysts. The company’s strategic outlook for 2025 indicates a focus on expanding their market presence and enhancing product offerings, aiming to capitalize on the growing demand for their treatments.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
